Literature DB >> 32289860

Effects of Native Fucosylated Glycosaminoglycan, Its Depolymerized Derivatives on Intrinsic Factor Xase, Coagulation, Thrombosis, and Hemorrhagic Risk.

Lutan Zhou1,2,3, Na Gao4, Huifang Sun2,3, Chuang Xiao5, Lian Yang2, Lisha Lin2,3, Ronghua Yin2, Zi Li2, Hongbin Zhang1, Xu Ji1,6, Jinhua Zhao2,4.   

Abstract

A native fucosylated glycosaminoglycan from sea cucumber Holothuria fuscopunctata (nHG), mainly branched with Fuc3S4S, exhibited potent anticoagulant activity by intrinsic tenase iXase (FIXa-FVIIIa complex) and antithrombin-dependent factor IIa (FIIa) inhibition, but also had the effects of FXII activation and platelet aggregation. For screening a selective iXase inhibitor, depolymerized nHG (dHG-1 ∼ -6) and a pure octasaccharide (oHG-8) were prepared. Like nHG, dHG-1 ∼ -6 and oHG-8 could potently inhibit iXase, and competitive binding assay indicated that dHG-5 and oHG-8 could bind to FIXa. Nevertheless, dHG-5 and oHG-8 had no effects on FXII and platelet activation. nHG, dHG-5, and oHG-8 could significantly prolong the activated partial thromboplastin time of human, rat, and rabbit plasma. In the rat deep venous thrombosis model, dHG-5 and oHG-8 showed potent antithrombotic effects in a dose-dependent manner, while the thrombus inhibition rate of nHG at high dose was markedly reduced. Additionally, dHG-5 and oHG-8 did not increase bleeding at the doses up to 10-fold of the effectively antithrombotic doses compared with nHG and low molecular weight heparin in the mice tail-cut model. Considering that dHG-5 possesses strong anti-iXase and antithrombotic activities, and its preparation process is simpler and its yield is higher compared with oHG-8, it might be a promising antithrombotic candidate. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32289860     DOI: 10.1055/s-0040-1708480

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  A Fucan Sulfate with Pentasaccharide Repeating Units from the Sea Cucumber Holothuriafloridana and Its Anticoagulant Activity.

Authors:  Zimo Ning; Pin Wang; Zhichuang Zuo; Xuelin Tao; Li Gao; Chen Xu; Zhiyue Wang; Bin Wu; Na Gao; Jinhua Zhao
Journal:  Mar Drugs       Date:  2022-06-03       Impact factor: 6.085

Review 2.  Marine Antithrombotics.

Authors:  Rohini Dwivedi; Vitor H Pomin
Journal:  Mar Drugs       Date:  2020-10-13       Impact factor: 5.118

3.  Pharmacokinetics and Pharmacodynamics of a Depolymerized Glycosaminoglycan from Holothuria fuscopunctata, a Novel Anticoagulant Candidate, in Rats by Bioanalytical Methods.

Authors:  Shuang Liu; Taocui Zhang; Huifang Sun; Lisha Lin; Na Gao; Weili Wang; Sujuan Li; Jinhua Zhao
Journal:  Mar Drugs       Date:  2021-04-11       Impact factor: 5.118

4.  Critical Quality Control Methods for a Novel Anticoagulant Candidate LFG-Na by HPSEC-MALLS-RID and Bioactivity Assays.

Authors:  Shunliang Zheng; Yi Wang; Jiashuo Wu; Siyao Wang; Huaifu Wei; Yongchun Zhang; Jianbo Zhou; Yue Shi
Journal:  Molecules       Date:  2022-07-15       Impact factor: 4.927

5.  Characterization of the Hydrolysis Kinetics of Fucosylated Glycosaminoglycan in Mild Acid and Structures of the Resulting Oligosaccharides.

Authors:  Xixi Liu; Zhexian Zhang; Hui Mao; Pin Wang; Zhichuang Zuo; Li Gao; Xiang Shi; Ronghua Yin; Na Gao; Jinhua Zhao
Journal:  Mar Drugs       Date:  2020-05-29       Impact factor: 5.118

6.  Structural Characterization and Heparanase Inhibitory Activity of Fucosylated Glycosaminoglycan from Holothuria floridana.

Authors:  Xiang Shi; Ruowei Guan; Lutan Zhou; Zhichuang Zuo; Xuelin Tao; Pin Wang; Yanrong Zhou; Ronghua Yin; Longyan Zhao; Na Gao; Jinhua Zhao
Journal:  Mar Drugs       Date:  2021-03-18       Impact factor: 5.118

7.  Antithrombotic Activity of Heparinoid G2 and Its Derivatives from the Clam Coelomactra antiquata.

Authors:  Guanlan Chen; Rui Zeng; Xin Wang; Hongying Cai; Jiajia Chen; Yingxiong Zhong; Saiyi Zhong; Xuejing Jia
Journal:  Mar Drugs       Date:  2022-01-05       Impact factor: 5.118

8.  The Toxicology of Native Fucosylated Glycosaminoglycans and the Safety of Their Depolymerized Products as Anticoagulants.

Authors:  Lisha Lin; Sujuan Li; Na Gao; Weili Wang; Taocui Zhang; Lian Yang; Xingzhi Yang; Dan Luo; Xu Ji; Jinhua Zhao
Journal:  Mar Drugs       Date:  2021-08-27       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.